• 제목/요약/키워드: 스티븐스-존슨증후군

검색결과 2건 처리시간 0.016초

소아 신증후군 환자에서 데플라자코트 치료 중 발생된 다형 홍반 3례 (Three Cases of Erythema Multiforme Developed during Deflazacort Therapy in Children with Nephrotic Syndrome)

  • 이승진;강봉화;조민현
    • Childhood Kidney Diseases
    • /
    • 제18권2호
    • /
    • pp.123-127
    • /
    • 2014
  • 다형 홍반은 피부, 구강, 입술 및 생식기 등을 침범하는 급성 피부점막 질환으로 점막 침범 여부에 따라 다형 홍반 minor와 다형 홍반 major로 분류된다. 스티븐스-존슨 증후군과 독성표피괴사용해는 다형 홍반 major에 속하는데, 이들은 증상이 심하고 진행성이며 높은 사망률을 보인다. 코르티코스테로이드는 현재 다형 홍반의 치료제로 사용되고 있다. 저자들은 신증후군을 가진 소아 환자에서 경구 코르티코스테로이드인 데플라자코트를 사용하던 중 발생된 3개의 다형 홍반 증례를 보고하는 바이다.

스티븐스-존슨증후군을 유발하는 주요 의약품별 위험도에 대한 체계적 문헌고찰 (A Systematic Review on the Causative Medicines for Stevens-Johnson Syndrome)

  • 권경은;정선영;정현주;김봉기;박병주
    • 한국임상약학회지
    • /
    • 제23권4호
    • /
    • pp.344-364
    • /
    • 2013
  • Background: Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are immune-complex-mediated hypersensitivity reactions that predominantly involve skin and mucous membranes. Despite the low incidence, both are considered medical emergencies as the mortality rate has been estimated at 30-50%. Although as many as half of cases are idiopathic, several drugs have been implicated as main cause of SJS/TEN. This review therefore aimed to identify drugs that were potentially associated with SJS/TEN and compare the relative risk of the medications. Method: A comprehensive search was performed using MEDLINE, EMBASE and 5 Korean databases. We defined study drugs as non-steroidal anti-inflammatory drugs (NSAIDs), antibiotics, antiepileptics, and allopurinol. Only epidemiologic studies investigating associations between the above drugs and drug-induced SJS/TEN were included. Two reviewers independently selected and evaluated candidate papers and extracted odds ratios or incidence rates. Meta-analysis was performed only for drugs that were reported from 4 or more studies. Results: We found 8 case-control studies, 3 cohort studies and 1 RCT. The ranges of adjusted ORs were 0.6-34.0 for NSAIDs, 1.6-302.0 for antiepileptics, 0.3-10.0 for antibiotics and 1.0-187.0 for allopurinol. The drug with the highest incidence of SJS/TEN was carbamazepine (40 persons/1,000 DDD). Conclusion: Finally, the risk was highest in first 8 weeks after onset of treatment in all drugs.